| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
and Induce Differentiation in Murine Keratinocytes1
University of Texas, M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957 [S. J. M., P. T., A. P., J. E. R., S. M. F.]; Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6602 [W. E. B., M. J., A. R. B.]
To determine the function and mechanism of action of the
8S-lipoxygenase (8-LOX) product of arachidonic
acid, 8S-hydroxyeicosatetraenoic acid
(8S-HETE), which is normally synthesized only after
irritation of the epidermis, transgenic mice with
8-LOX targeted to keratinocytes through the use
of a loricrin promoter were generated. Histological analyses showed
that the skin, tongue, and stomach of transgenic mice are highly
differentiated, and immunoblotting and immunohistochemistries of skin
showed higher levels of keratin-1 expression compared with wild-type
mice. The labeling index, however, of the transgenic epidermis was
twice that of the wild-type epidermis. Furthermore,
8S-HETE treatment of wild-type primary keratinocytes
induced keratin-1 expression. Peroxisome proliferator activated
receptor
(PPAR
) was identified as a crucial component of
keratin-1 induction through transient transfection with expression
vectors for PPAR
, PPAR
, and a dominant-negative PPAR, as well as
through the use of known PPAR agonists. From these studies, it is
concluded that 8S-HETE plays an important role in
keratinocyte differentiation and that at least some of its effects are
mediated by PPAR
.
This article has been cited by other articles:
![]() |
K. R. Feingold Thematic review series: Skin Lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis J. Lipid Res., December 1, 2007; 48(12): 2531 - 2546. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schweiger, G. Furstenberger, and P. Krieg Inducible expression of 15-lipoxygenase-2 and 8-lipoxygenase inhibits cell growth via common signaling pathways J. Lipid Res., March 1, 2007; 48(3): 553 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fang, S. Hu, B. Xu, G. D. Snyder, S. Harmon, J. Yao, Y. Liu, B. Sangras, J. R. Falck, N. L. Weintraub, et al. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-{alpha} Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H55 - H63. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Totary-Jain, T. Naveh-Many, Y. Riahi, N. Kaiser, J. Eckel, and S. Sasson Calreticulin Destabilizes Glucose Transporter-1 mRNA in Vascular Endothelial and Smooth Muscle Cells Under High-Glucose Conditions Circ. Res., November 11, 2005; 97(10): 1001 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kim, S. J. Muga, and S. M. Fischer Identification and Characterization of a Phorbol Ester-responsive Element in the Murine 8S-Lipoxygenase Gene J. Biol. Chem., March 19, 2004; 279(12): 11188 - 11197. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Kozak, R. A. Gupta, J. S. Moody, C. Ji, W. E. Boeglin, R. N. DuBois, A. R. Brash, and L. J. Marnett 15-Lipoxygenase Metabolism of 2-Arachidonylglycerol. GENERATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR alpha AGONIST J. Biol. Chem., June 21, 2002; 277(26): 23278 - 23286. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shureiqi and S. M. Lippman Lipoxygenase Modulation to Reverse Carcinogenesis Cancer Res., September 1, 2001; 61(17): 6307 - 6312. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |